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tient described gave her informed consent for being re-
viewed in this work.
Clinical Case
A 36-year-old female patient, who gave birth by caesar-
ean section 2 weeks earlier, was examined in the Depart-
ment of Orthopedic Surgery Outpatient Clinic because of 
pain in her right hip. The analysis identifi ed a fracture in 
the upper branches of the right pubic bone and the patient 
was hospitalized for further treatment. From her sixth 
month of pregnancy the patient experienced bilateral lum-
bar pain. She was examined by an orthopedist who con-
cluded lumboischialgia, but X-ray diagnostics were not 
performed due to the pregnancy. Also in the sixth month 
of pregnancy she was diagnosed with extirpated tumor 
formation in the lower right jaw. Histopathology was found 
to be a gigantocellular granuloma. Ten months prior to 
pregnancy the patient underwent a left adnexectomy due 
Primary hyperparathyroidism usually presents as hy-
percalcemia in an otherwise asymptomatic patient, or 
with complications such as nephrocalcinosis, osteoporosis, 
or a severe psychoneurologic disorder1. It is most frequent-
ly caused by a single parathyroid gland adenoma1. Rarely, 
primary hyperparathyroidism can even be caused by para-
thyroid carcinoma (in about 0.5–5%)2,3, and an adenoma 
can be localized ectopically4–6. In many cases, primary 
hyperparathyroidism and parathyroid gland adenoma can 
represent a diagnostic and therapeutic challenge because 
it is often not recognized correctly and at an appropriate 
time point. Timely diagnosis is, however, crucial in a clin-
ical setting and can be vital for the patient involved. In 
this report, we are reviewing a case of suspected meta-
static cancer at initial presentation, which – after thor-
ough additional investigation – was in fact revealed to be 
a parathyroid adenoma. The report illustrates the neces-
sity of taking this disease into consideration in diagnostic 
workups of suspected oncologic patients and describes one 
of the many faces of parathyroid gland adenoma. The pa-
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A B S T R A C T
We present a 36 year old female patient with suspected postpartum advanced metastatic cancer and multiple osteo-
lytic lesions due to which she was referred to the Internal medicine clinic for further diagnostic evaluation. After extensive 
investigation, it was discovered that the underlying condition was a parathyroid gland adenoma and the patient was 
treated surgically. Clinicians should note that parathyroid adenoma can mimic metastatic malignant disease, and should 
make appropriate diagnostic tests that will lead to the correct diagnosis.
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to ovarian endometriosis. The patient’s family history in-
cluded a father with angina pectoris and a mother who 
was diagnosed with breast cancer at the age of 64 years. 
Radiographs of the lungs and heart were normal. In the 
projections of the rear tail ends of the ribs there were 
round, reasonably well limited soft tissue shadows with 
pathological fractures of the modifi ed bone, to the right and 
left of the 5th–7th rib, which suggested metastatic changes 
in the ribs. Abdominal ultrasound fi ndings were normal 
with hyperechoic bilateral renal parenchyma. The breast 
ultrasound showed numerous cystic zones that correspond-
ed to dilated milk ducts, considered normal because the 
patient was nursing. Computed tomography of the thorax 
and abdomen showed a set of oval shaped bulges and areas 
of bone destruction up to 2.5 cm in diameter, positioned 
symmetrically at the rear ends of upper ribs, and multiple 
zones of destruction within several vertebrae and espe-
cially in the fi fth lumbar vertebral body to the right con-
sistent with osteolytic processes. Normal fi ndings of the 
lungs, heart, upper abdominal organs and kidneys were 
reported. Computed tomography of the pelvis showed a 
hypodense expansive lesion 6×3 cm in diameter in the 
small joint of the fi fth lumbar vertebra to the right which 
went on to destroy and infi ltrate the vertebral body extend-
ing into the right neural recess. Inside the pelvic bones 
several osteolytic zones up to 2.5 cm in diameter were re-
vealed, the most numerous along the left sacroiliac junc-
ture, some of which destroyed the bone cortex. Another 
identical zone was at the base of the upper branch of the 
right pubic bone with pathological fracture of the bone. The 
uterus was enlarged corresponding to the condition 4 
weeks after birth. It was concluded that these changes in-
dicated metastatic bone lesions. 
The main laboratory fi ndings showed a slightly elevat-
ed leukocyte count (11.2×109/L with 79% neutrophilic 
granulocytes and lymphocytes 15%), mild normocytic ane-
mia (hemoglobin 113 g/L), slightly increased platelet count 
(468×109/L), mildly decreased protein (61.1 g/L) and albu-
min (34.2 g/L), alkaline phosphatase (541 U/L), mildly 
elevated creatinine (90 μmol/L, reference value to 80) and 
normal phosphates, total bilirubin, alanine transaminase 
(AST), aspartate aminotansaminase (ALT), gamma-glu-
tamyl transpeptidase (GGT), lactate dehydrogenase (LD), 
urea, sodium and potassium, glucose and C-reactive pro-
tein (CRP). Findings of tumor markers (CA 15-3, CA 125, 
alpha fetoprotein (AFP) and CA 19-9) were normal with 
mildly elevated beta human chorionic gonadotropin (β 
HCG) levels. To determine the primary tumor the patient 
underwent positron emission tomography (PET/CT)–an 
established method for the visualization of tumors of un-
known origin and localization7, which visualized intense 
pathological accumulation of fl uorodeoxyglucose (FDG) in 
multiple regions of the skeleton (cranial bones, most nota-
bly in the right angulus of the mandible, in the left maxil-
lary sinus and in the right side of the epipharynx, in upper 
arms, shoulder girdle bones, ribs, left and right sides of 
the thorax, thoracic and lumbar vertebrae, pelvis and up-
per leg) (Figure 1). A focal increase of metabolism was 
accentuated in the parenchyma of the right kidney. It was 
concluded that the fi ndings suggest secondary metastatic 
changes. A review by an endocrinologist was requested. 
We performed additional processing. Elevated levels of 
total (3.43 mmol/L, reference interval 2.14 to 2.53) and 
ionized calcium (2.01 mmol/L, reference interval 1.13 to 
1.32) were found with multiple elevated PTH (170.04, 
236.88 and 251.27 pg/mL, reference range 6–29), and el-
evated alkaline phosphatase (455 U/L, reference interval 
54–119) and normal phosphates in serum and 24 hour 
urine. Calcium in 24 hour urine was mistakenly not run, 
but this was corrected by the testing of calcium in the 
morning urine – it was found elevated (calcium/creatinine 
1.83; reference interval 0.05 to 0.60). Thyroid ultrasound 
revealed a marginally elongated right lobe and an en-
larged left lobe with nodal changes in both lobes and the 
lower two thirds of the left lobe were occupied by a hy-
poechoic node with good blood supply and a size of 
5.0×2.4×2.3 cm (Figure 2). Cytological analysis of a fi ne 
needle biopsy sample suggested parathyroid neoplasm, 
which was confi rmed by determining PTH levels in the 
sample – 1415 pg/mL, with a second (control) determina-
tion of PTH levels yielding an immeasurably high result, 
higher than 2500 pg/mL (reference range 6–29) with nor-
mal thyroglobulin in the aspirate. In the right subman-
dibula a hypoechoic node was observed, surrounded by a 
hyperechoic rim (dimensions 3.1×2.8×2.8cm); in the cyto-
logical aspirate there were numerous osteoclasts. Densi-
tometry of the spine revealed osteoporosis (T-score –4.6), 
hip (right hip T-score –5.0, left hip: –2.7) and forearm (T-
score –3.4) with elevated osteocalcin (87.49 ng/mL, refer-
ence range 5–25) and pyrilinks D (37.53 nM DPD/mM; 
reference interval from 3.0 to 7.4) and mildly decreased 
25 (OH) vitamin D (46.9 pmol/L). Detection of thyroid-
stimulating hormone (TSH) was normal with minimally 
decreased free thyroxine (FT4) and normal anti-thyroid 
peroksidase (anti-TPO). Incurred additional tumor mark-
ers carcinoembryonic antigen (CEA), NSE, chromogranin 
A, CA 72–4, CA 242, CYFRA 21–1 and repeated fi ndings 
of β HCG were normal. Other repeated laboratory fi ndings 
showed no changes with a proper value of erythrocyte 
sedimentation rate and normal leukocytes and platelets. 
Electrophoresis and immunoelectrophoresis fi ndings of 
serum proteins were normal, while free lambda light 
chains and caps in the serum and urine were markedly 
elevated with a normal ratio. After infusion of 0.9% NaCl 
with the diuretic furosemide Furosemide intravenously, 
there was a decrease in total (3.31 and 3.11 mmol/L) and 
ionized (2.01 and 1.85 mmol/L) calcium. The evaluation 
included review by maxillofacial surgeons, who concluded 
that the panoramic radiograph fi ndings suggest hyper-
parathyroidism with the earlier pathologic fi nding of oral 
gigantocellular granuloma fi tting well in. A dermatologist 
was consulted to rule out possible metastases of malignant 
melanoma. It was recommended that the histopathologic 
material previously removed from the oral tumor forma-
tion should be used for immunohistochemical staining for 
melanoma markers and Menkelcell carcinoma. Addition-
ally, dermatoscopic examination of nevus-like skin lesions 
was advised. All these fi ndings were normal. Gynecologi-
cal control examination was normal. Parathyroid scintig-
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Fig. 2. Thyroid ultrasound showing lobe enlargement and nodal changes.
Fig. 1. PET/CT with intense pathological accumulation of fl uorodeoxyglucose (FDG) in multiple regions of the skeleton.
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raphy has not been performed, because the family ar-
ranged to continue treatment at the Clinic for Tumors in 
another facility. 
After the patient transfer was made, she underwent 
surgery to extirpate the left lower parathyroid gland. PTH 
before surgery was highly elevated (511 pg/mL, reference 
range up to 69), borderline (78.43 pg/mL) immediately 
after surgery, and normal (40.37 pg/mL) on the day after 
surgery. She was given calcium carbonate tablets 3×1 
gram per day for therapy. Her son had a seizure and was 
hospitalized at the pediatric hospital. The child was diag-
nosed with hypocalcaemia. Following reimbursement of 
calcium and vitamin D, calcium levels were normal and 
the child was clinically well. The patient presented for a 
control examination after a month. PTH was still in nor-
mal range with normal values  of total and ionized calcium 
and phosphate in serum and 24 hour urine. Calcium ci-
trate tablets 2000 mg and calcitriol 0.5 mg (Rocaltrol cap-
sules) were recommended to her as further therapy.
Conclusion
Although patients with parathyroid gland adenoma are 
mostly asymptomatic with hypercalcemia, uncommon pre-
sentations of this clinical condition have been described 
before, such as hemorrhagic neck masses and recurrent 
laryngeal nerve paralysis with dysphonia8,9, general bone 
pains10, quadriparesis11, associations with other tu-
mors12–15, osteitis fi brosa cystic16 and others. Parathyroid 
gland adenoma has been reported during pregnancy17,18.
In our case, a female patient who gave birth 2 weeks 
before presenting to our clinic, had radiological fi ndings 
of multiple osteolytic lesions which suggested advanced 
metastatic disease. During pregnancy, an oral tumor was 
removed and pathologically identifi ed as a gigantocellular 
granuloma. Prior to the pregnancy, she underwent adnex-
ectomy because of endometriosis. After careful diagnostic 
follow-up, we concluded that the patient had in fact pri-
mary hyperparathyroidism associated with a parathyroid 
gland adenoma, which was managed effectively. 
Parathyroid adenoma can mimic metastatic disease in 
certain cases. When presented with a suspected meta-
static disease, with multiple osteolytic foci of the skeleton, 
a clinician should also keep in mind that a parathyroid 
adenoma can be a primary cause of such changes instead 
of metastatic cancer and that a broad differential diagno-
sis with additional tests such as total and ionized serum 
calcium and PTH (followed by thyroid imaging19 and bi-
opsy) in such circumstances can be extremely helpful for 
a timely and precise diagnosis. 
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OD POSTPOROĐAJNOG METASTATSKOG TUMORA DO ADENOMA PARATIREOIDNE ŽLIJEZDE 
S A Ž E T A K 
Prikazuje se 36-godišnja bolesnica sa sumnjom na poslijeporođajni uznapredovali metastatski karcinom i s višestrukim 
osteolitičkim lezijama zbog čega je upućena na Internu kliniku radi daljnje dijagnostičke obrade. Nakon opsežne obrade, 
otkriveno je da se radi o adenomu paratireoidne žlijezde te je bolesnica operativno liječena. Kliničari trebaju imati na 
umu da adenom paratireoidne žlijezde može oponašati metastatsku malignu bolest te trebaju učiniti odgovarajuće 
dijagnostičke pretrage koje će uputiti na dijagnozu.
